Skip to content

Maternal-Fetal Monitoring by Connected Abdominal Patch - MOMA

Maternal-Fetal Monitoring by Connected Abdominal Patch - MOMA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05263427
Acronym
MOMA
Enrollment
60
Registered
2022-03-02
Start date
2022-08-31
Completion date
2023-11-03
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monitoring Injury of Scalp of Newborn, Obstetrical Complications

Keywords

Fetal Heart Rate, Monitoring, Uterine contraction, Electrocardiogram

Brief summary

During a previous clinical trial (RCF-abdo: 2018-A01194-51), trans-abdominal signals were collected in 90 patients at the maternity Jeanne de Flandre. This database allowed us to develop a new medical device able to measure in real time and continuously the fetal heart rate and the uterine contractions. The goal here is to assess the performance of the device in real situation during labour. This study will be carried out in the maternity labor ward in CHU Lille, France. The TOCONAUTE will be placed on the mother's abdomen to capture fetal and maternal heart rate as well as the uterine contractions in parallel of the cardiotocograph. For each of the participants, the TOCONAUTE will remain on the mother's abdomen till childbirth. This procedure will not affect the usual care of the patient.

Interventions

DEVICETOCONAUTE

This study will be carried out during delivery. The will be placed on the mother's abdomen to capture fetal and maternal heart rate as well as the uterine contractions in parallel of the cardiotocograph. For each of the participants, the TOCONAUTE will remain on the mother's abdomen till childbirth. This procedure will not affect the usual care of the patient.

Sponsors

Clinical Investigation Centre for Innovative Technology Network
CollaboratorNETWORK
BioSerenity
CollaboratorINDUSTRY
National Research Agency, France
CollaboratorOTHER
University Hospital, Lille
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant woman in labor * Singleton * Cephalic presentation

Exclusion criteria

* Hospitalisation for a medical termination of pregnancy * Death in utero * Multiple pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Fetal heart rate with the TOCONAUTE1 yearThe fetal heart rate from the our device will be averaged on 3 beats and resampled at 4Hz to be comparable to the fetal heart rate from the cardiotocograph. Both of the signals will be resynchronized and compared sample by sample with a Pearson's correlation test. Measure of the fetal heart rate with the TOCONAUTE compared to the measure of the fetal heart rate with a cardiotocograph.

Secondary

MeasureTime frameDescription
Uterine contractions with the TOCONAUTE according to the different phase of labor.1 yearMeasure of the uterine contractions with the TOCONAUTE compared to the measure of the uterine contractions with a cardiotocograph according to the different phase of labor. Both signals of the uterine contractions will be resynchronized and compared sample by sample with a Pearson's correlation test.
Maternal heart rate with the TOCONAUTE1 yearMeasure of the maternal heart rate with the TOCONAUTE compared to the measure of the maternal heart rate with a cardiotocograph. Both signals of the maternal heart rate will be resynchronized and compared sample by sample with a Pearson's correlation test.
Fetal heart rate with the TOCONAUTE according to the different phase of labor.1 yearMeasure of the fetal heart rate with the TOCONAUTE compared to the measure of the fetal heart rate with a cardiotocograph according to the different phase of labor.
Fetal stress index (Heart rate variability index reflecting parasympathetic fluctuation)1 yearFeasibility of the measure of the Fetal stress index (Heart rate variability index reflecting parasympathetic fluctuation)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026